Login / Signup
Letter: overcoming secondary loss of response to infliximab-it is not the drug, it is how you use it! Authors' reply.
Erwin Dreesen
Ann Gils
Published in:
Alimentary pharmacology & therapeutics (2019)
Keyphrases
</>
ulcerative colitis
adverse drug
drug induced